{
    "nctId": "NCT03407040",
    "briefTitle": "Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy",
    "officialTitle": "Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential Future Therapy",
    "overallStatus": "TERMINATED",
    "conditions": "Gastrointestinal Cancers, Breast Cancer, Pancreatic Cancer, Melanoma, Lung Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 98,
    "primaryOutcomeMeasure": "Production of cancer antigen-specific T-cells",
    "eligibilityCriteria": "* INCLUSION CRITERIA:\n* Patients with a cancer diagnosis enrolled on protocol 03-C-0277.\n* Willing and able to provide informed consent\n* Patients must be greater than or equal to 15 years of age.\n\nEXCLUSION CRITERIA:\n\n-Healthy donors enrolled on protocol 03-C-0277.",
    "sex": "ALL",
    "minimumAge": "15 Years",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}